The Asia Pacific glucose monitoring system CGMS market is anticipated to grow at a CAGR of 24.60%, and the SMBG market is predicted to record a CAGR of 6.27% over the projected period of 2019-2028. The rising incidence of diabetes is one of the significant factors propelling market growth in the region. In order to analyze the growth rate of the Asia Pacific glucose monitoring market, the region is segregated into India, Malaysia, Thailand, China, Indonesia, South Korea, Philippines, Japan, Australia, Vietnam, and the rest of Asia Pacific. In China, 11% of the people are suffering from diabetes, which is the largest diabetic population in the world due to growing affluence, and lack of physical activity.

ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

Asia Pacific Glucose Monitoring System Market by Component Type (Sensors, Transmitters and Receivers, Insulin Pump) by End-users (Home Settings, Diagnostics and Clinics, Hospitals) by Demographics (Adult Population (>14years), Child Population (≤14years)) by Component Type (Test Strips, Glucose Meter, Lancets) by End-user (Home Settings, Clinical, Hospital) by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) by Geography.

Request free sample

Report Summary

To know more about this report, request a free sample copy

In order to analyze the growth rate of the Asia Pacific glucose monitoring market, the region is segregated into India, Malaysia, Thailand, China, Indonesia, South Korea, Philippines, Japan, Australia, Vietnam, and the rest of Asia Pacific. In China, 11% of the people are suffering from diabetes, which is the largest diabetic population in the world due to growing affluence, and lack of physical activity. China’s pharmaceutical market is expanding, but the industry is suffering from minimal innovation and R&D investment. The Chinese healthcare industry is developing rapidly and has strong growth potential. India has a high prevalence of diabetes, and immense scope for the GMS market. CGMS is still a specialty product in India. The pharmaceutical regulations improved with the passing of a bill in 2005, and the large pool of scientists and engineers are driving the sector. India is the biggest provider of generic medications worldwide. Australia has a developed healthcare system, and the biggest challenge facing the healthcare system is diabetes. Every day 280 Australians develop diabetes.

In Japan, about 7.6% of adults aged between 20 and 29 are diabetic. The government offers two main programs, one for people who are 74 or younger, and another program for 75 or older. The Japanese are covered by one of the public health insurance programs. In South Korea, diabetes has become a major cause of mortality and morbidity. The healthcare system is run by the Ministry of Health and Welfare, and is free for all its citizens.

I-SENS, based in South Korea, invests heavily in new product R&D, and boasts of one the largest built glucose strip production facilities in the world. I-SENS products are known for their high quality and accuracy. In Jan 2019, I-SENS announced its partnership with IDF.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARIES
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
  - RISE IN THE INCIDENCE OF DIABETES
  - INCREASE IN HEALTHCARE EXPENDITURE
  - INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
  - TECHNOLOGY INTEGRATION
  - INCREASING CGMS AND SMBG AFFORDABILITY
  - TECHNOLOGICAL ADVANCES IN GMS DEVICES
  - AWARENESS AMONG THE GENERAL POPULATION
- KEY RESTRAINTS
  - HINDRANCE FROM GOVERNMENT REGULATIONS
  - INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
  - LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
  - INTENSE COMPETITION AMONG VENDORS
  - INACCURACY IN READING OF GMS DEVICES

KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
  - THREAT OF NEW ENTRY
  - THREAT OF SUBSTITUTION
  - BUYER’S POWER
  - SUPPLIER’S POWER
  - COMPETITIVE RIVALRY
- KEY BUYING CRITERIA
- REGULATION OF BLOOD SUGAR
- VALUE CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
CGMS MARKET BY COMPONENT TYPE
- SENSORS
- TRANSMITTER AND RECEIVERS
- INTEGRATED INSULIN PUMPS
CGMS MARKET BY END-USER
- HOME SETTINGS
- DIAGNOSTICS AND CLINICAL
- HOSPITAL
CGMS MARKET BY DEMOGRAPHICS
- ADULT POPULATION (>14YEARS)
- CHILD POPULATION (≤14YEARS)
SMBG MARKET OVERVIEW
SMBG MARKET BY COMPONENT TYPE
- TEST STRIPS
- GLUCOSE METER
- LANCETS
SMBG MARKET BY END-USER
- HOME SETTINGS
- CLINICAL
- HOSPITAL
SMBG MARKET BY APPLICATION
- TYPE 1 DIABETES
- TYPE 2 DIABETES
- GESTATIONAL DIABETES
GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
  - CHINA
    - CHINA HEALTH AND HEALTHCARE
    - CHINA PHARMACEUTICAL MARKET
    - CHINA DIABETES MARKET
    - MARKET TRENDS
  - INDIA
    - INDIA HEALTH AND HEALTHCARE
    - INDIA REGULATORY CHANGES
    - INDIA PHARMACEUTICAL MARKET
    - INDIA DIABETES MARKET
  - AUSTRALIA
    - MARKET TRENDS
  - JAPAN
    - JAPAN HEALTH AND HEALTHCARE
    - JAPAN PHARMACEUTICAL MARKET
    - JAPAN DIABETES MARKET
    - MARKET TRENDS
  - SOUTH KOREA
    - MARKET TRENDS
  - INDONESIA
    - MARKET TRENDS
  - MALAYSIA
    - MARKET TRENDS
  - PHILIPPINES
    - MARKET TRENDS
  - THAILAND
    - MARKET TRENDS
  - VIETNAM
    - MARKET TRENDS
  - REST OF APAC

COMPANY PROFILES
- ABBOTT
- APEX BIOTECHNOLOGY CORPORATION
- ARKRAY INC
- ASCENSIA
- B BRAUN MELSUNGEN AG
- BECTON DICKINSON AND COMPANY
- DEXCOM
- GLYSENS INC
- INSULET CORP
- I-SENS INC
- JOHNSON AND JOHNSON
- MEDTRONIC
- MOREPEN LABORATORIES LTD
- NEMAURA MEDICAL INC
- ROCHE DIAGNOSTICS
- SENSEONICS INC
- TANDEM DIABETES CARE
- TERUMO
- WOCKHARDT
- YPSOMED

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – GLUCOSE MONITORING SYSTEM

TABLE 2: DIABETES PREVALENCE IN ASIA PACIFIC 2015-2040 (MILLIONS)

TABLE 3: ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: ASIA PACIFIC CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: ASIA PACIFIC CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: ASIA PACIFIC CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: ASIA PACIFIC CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 10: PRODUCT MATRIX FOR LANCETS

TABLE 11: ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 13: ASIA PACIFIC SMBG MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 14: ASIA PACIFIC SMBG MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 15: ASIA PACIFIC SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 16: ASIA PACIFIC SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 17: ASIA PACIFIC CGMS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: ASIA PACIFIC CGMS, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 19: ASIA PACIFIC SMBG, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 20: ASIA PACIFIC SMBG, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 21: AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE 22: CHINA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 23: AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 24: INDIA SMBG SALES CHANNEL 2019-2028 ($ MILLION)

TABLE 25: AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 26: AUSTRALIA SMBG SALES CHANNEL 2019-2028 ($ MILLION)

TABLE 27: AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 28: JAPAN SALES CHANNEL 2019-2028 ($ MILLION)

TABLE 29: AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 30: SOUTH KOREA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 31: AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 32: INDONESIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 33: AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 34: MALAYSIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 35: AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 36: PHILIPPINES SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 37: AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 38: THAILAND SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 39: AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 40: VIETNAM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: VALUE CHAIN OF CGMS MARKET

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 7: ASIA PACIFIC CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)

FIGURE 8: ASIA PACIFIC CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)

FIGURE 9: ASIA PACIFIC CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)

FIGURE 10: ASIA PACIFIC CGMS MARKET, BY END-USER, IN 2019

FIGURE 11: ASIA PACIFIC CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 12: ASIA PACIFIC CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 13: ASIA PACIFIC CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 14: ASIA PACIFIC CGMS MARKET, BY DEMOGRAPHICS, IN 2019

FIGURE 15: ASIA PACIFIC CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 16: ASIA PACIFIC CGMS MARKET, BY CHILD POPULATION (≤14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 17: ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 18: ASIA PACIFIC SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)

FIGURE 19: ASIA PACIFIC SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)

FIGURE 20: ASIA PACIFIC SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)

FIGURE 21: ASIA PACIFIC SMBG MARKET, BY END-USER, IN 2019

FIGURE 22: ASIA PACIFIC SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 23: ASIA PACIFIC SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 24: ASIA PACIFIC SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 25: ASIA PACIFIC SMBG MARKET, BY APPLICATION, IN 2019

FIGURE 26: ASIA PACIFIC SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 27: ASIA PACIFIC SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 28: ASIA PACIFIC SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 29: ASIA PACIFIC CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 30: ASIA PACIFIC SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 31: CHINA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 32: CHINA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: INDIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: INDIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 35: AUSTRALIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 36: AUSTRALIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 37: JAPAN CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 38: JAPAN SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 39: SOUTH KOREA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 40: SOUTH KOREA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 41: INDONESIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 42: INDONESIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 43: MALAYSIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 44: MALAYSIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 45: PHILIPPINES CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 46: PHILIPPINES SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 47: THAILAND CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 48: THAILAND SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 49: VIETNAM CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 50: VIETNAM SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 51: REST OF APAC CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 52: REST OF APAC SMBG MARKET, 2019-2028 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
  - CHINA
    - CHINA HEALTH AND HEALTHCARE
    - CHINA PHARMACEUTICAL MARKET
    - CHINA DIABETES MARKET
    - MARKET TRENDS
  - INDIA
    - INDIA HEALTH AND HEALTHCARE
    - INDIA REGULATORY CHANGES
    - INDIA PHARMACEUTICAL MARKET
    - INDIA DIABETES MARKET
  - AUSTRALIA
    - MARKET TRENDS
  - JAPAN
    - JAPAN HEALTH AND HEALTHCARE
    - JAPAN PHARMACEUTICAL MARKET
    - JAPAN DIABETES MARKET
    - MARKET TRENDS
  - SOUTH KOREA
    - MARKET TRENDS
  - INDONESIA
    - MARKET TRENDS
  - MALAYSIA
    - MARKET TRENDS
  - PHILIPPINES
    - MARKET TRENDS
  - THAILAND
    - MARKET TRENDS
  - VIETNAM
    - MARKET TRENDS
  - REST OF APAC

CGMS MARKET BY COMPONENT TYPE
- SENSORS
- TRANSMITTER AND RECEIVERS
- INTEGRATED INSULIN PUMPS
CGMS MARKET BY END-USER
- HOME SETTINGS
- DIAGNOSTICS AND CLINICAL
- HOSPITAL
CGMS MARKET BY DEMOGRAPHICS
- ADULT POPULATION (>14YEARS)
- CHILD POPULATION (≤14YEARS)
SMBG MARKET OVERVIEW
SMBG MARKET BY COMPONENT TYPE
- TEST STRIPS
- GLUCOSE METER
- LANCETS
SMBG MARKET BY END-USER
- HOME SETTINGS
- CLINICAL
- HOSPITAL
SMBG MARKET BY APPLICATION
- TYPE 1 DIABETES
- TYPE 2 DIABETES
- GESTATIONAL DIABETES